Population Pharmacokinetics of Nivolumab in Combination With Ipilimumab in Patients With Advanced Malignancies

Nivolumab is a fully human monoclonal antibody that inhibits programmed cell death‐1 activation. To assess covariate effects on nivolumab clearance (CL), a population pharmacokinetics model was developed using data from 6,468 patients with colorectal cancer, hepatocellular carcinoma, melanoma, non‐s...

Full description

Saved in:
Bibliographic Details
Main Authors: Jason Zhang (Author), Kinjal Sanghavi (Author), Jun Shen (Author), Xiaochen Zhao (Author), Yan Feng (Author), Paul Statkevich (Author), Jennifer Sheng (Author), Amit Roy (Author), Li Zhu (Author)
Format: Book
Published: Wiley, 2019-12-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available